Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
As the most abundant natural flavonoid in rattan tea, dihydromyricetin (DMY) has shown a wide range of pharmacological effects. In addition to the general characteristics of flavonoids, DMY has the effects of cardioprotection, anti-diabetes, hepatoprotection, neuroprotection, anti-tumor, and dermatoprotection. DMY was also applied for the treatment of bacterial infection, osteoporosis, asthma, kidney injury, nephrotoxicity and so on. These effects to some extent enrich the understanding about the role of DMY in disease prevention and therapy. However, to date, we still have no outlined knowledge about the detailed mechanism of DMY, which might be related to anti-oxidation and anti-inflammation. And the detailed mechanisms may be associated with several different molecules involved in cellular apoptosis, oxidative stress, and inflammation, such as AMP-activated protein kinase (AMPK), mitogen-activated protein kinase (MAPK), protein kinase B (Akt), nuclear factor-κB (NF-κB), nuclear factor E2-related factor 2 (Nrf2), ATP-binding cassette transporter A1 (ABCA1), peroxisome proliferator-activated receptor-γ (PPARγ) and so on. Here, we summarized the current pharmacological developments of DMY as well as possible mechanisms, aiming to push the understanding about the protective role of DMY as well as its preclinical assessment of novel application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyphenols and bioavailability: an update
Teng, H., & Chen, L. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1437023 · Cited by 336 · cited 1×
“Many experiments found that polyphenolics had low oral bioavailability (Teng and Chen, 2018).”
BackgroundChen, L., Teng, H., Xie, Z., Cao, H., Cheang, W. S., Skalicka-Woniak, K., Georgiev, M. I., & Xiao, J. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1196334 · Cited by 291
Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga, C., Beretta, G., Pl, V., Gr, L., Pollini, C., Bonadonna, G., Canetta, R. M., Castellani, R., Villa, E., Cg, G., et al. (1979) · PubMed · Cited by 248
Chen, S., Zhao, X., Wan, J., Ran, L., Qin, Y., Wang, X., Gao, Y., Shu, F., Zhang, Y., Liu, P., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.009 · Cited by 235
Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication
Shen, Y., Lindemeyer, A. K., Gonzalez, C., Shao, X. M., Spigelman, I., Olsen, R. W., & Liang, J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4639-11.2012 · Cited by 213
Hu, Q., Zhang, T., Yi, L., Zhou, X., & Mi, M. (2018) · BioFactors · doi:10.1002/biof.1395 · Cited by 180
Zeng, X., Yang, J., Hu, O., Huang, J., Ran, L., Chen, M., Zhang, Y., Zhou, X., Zhu, J., Zhang, Q., et al. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7172 · Cited by 163
Wu, Y., Bai, J., Zhong, K., Huang, Y., & Gao, H. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2016.07.090 · Cited by 160
Meng, G., Liu, J., Liu, S., Song, Q., Liu, L., Xie, L., Han, Y., & Ji, Y. H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13861 · Cited by 126
Self-citationHou, X., Tong, Q., Wang, W., Xiong, W., Shi, C., & Fang, J. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.03.007 · Cited by 115
Shi, L., Zhang, T., Zhou, Y. G., Zeng, X., Ran, L., Zhang, Q., Zhu, J., & Mi, M. (2015) · Endocrine · doi:10.1007/s12020-015-0599-5 · Cited by 112 · cited 1×
“These data suggested that DMY induced mitochondriamediated apoptosis in HepG2 cells via Akt/Bad pathway downregulation (Zhang et al., 2017).”
BackgroundTang, L., Dai, F., Liu, Y., Yu, X., Huang, C., Wang, Y., & Yao, W. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.05.011 · Cited by 112
Kou, X., Liu, X., Chen, X., Li, J., Yang, X., Fan, J., Yang, Y., & Chen, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12811 · Cited by 108 · cited 1×
“DMY significantly inhibited apoptosis and rescued dysfunctional autophagy of neurons in hippocampus of D-gal-induced brain aging model of rats through sirtuin 1 (SIRT1) up-regulation and p53/p21 as well as mammalian target of rapamycin (mTOR) down-regulation via a miR-34a dependent manner (Kou et al., 2016).”
BackgroundQiu, P., Dong, Y. H., Li, B., Kang, X., Gu, C., Zhu, T., Luo, Y., Pang, M.-X., Du, W., & Ge, W. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.04.009 · Cited by 106
Ren, Z., Zhao, Y.-F., Cao, T., & Zhen, X.-C. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.42 · Cited by 103
Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice
Liu, T. T., Zeng, Y., Tang, K., Chen, X., Zhang, W., & Xu, X. L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.003 · Cited by 100 · cited 2×
“DMY also prevented oxidative stress in the liver of LDL receptor deficient (LDLr−/−) mice with HFD, which might be related to normalizing antioxidant enzymes’ activities to suppress ROS generation and NOX2 expression (Liu et al., 2017).”
BackgroundLe, L., Jiang, B., Wan, W., Zhai, W., Xu, L., Hu, K., & Xiao, P. (2016) · Scientific Reports · doi:10.1038/srep36184 · Cited by 91 · cited 2×
“DMY also ameliorated phosphorylation of Akt2 at Ser474 and IRS-1 at Ser612, decreased GSK3β phosphorylation, and down-regulated glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate caroxykinase (PEPCK) expression in HepG2 cells with high glucose stimulation (Le et al., 2016).”
BackgroundXie, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i18.5473 · Cited by 90 · cited 1×
“Furthermore, c-Jun N-terminal kinase (JNK) inhibitor SP600125 attenuated TNF-α expression decrease and survival rate enhancement of ALF after DMY treatment, which suggested that DMY alleviated CCl4-induced acute liver injury via a JNK-dependent manner (Xie et al., 2015).”
BackgroundDihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
Wu, B., Lin, J. M., Luo, J., Han, D. H., Fan, M., Guo, T., Tao, L., Yuan, M., & Yi, F. (2017) · BioMed Research International · doi:10.1155/2017/3764370 · Cited by 82
Liu, S., Ai, Q., Feng, K., Li, Y., & Liu, X. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1306-6 · Cited by 79
Chen, Y., Luo, H., Sun, L., Mr, X., Yu, J. M., Liu, L., Zhang, J., Wang, Y., Wang, H., Bao, X., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092592 · Cited by 74
Self-citationBiased β2‐adrenoceptor signalling in heart failure: pathophysiology and drug discovery
Woo, A. Y., Song, Y., Xiao, R., & Zhu, W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12965 · Cited by 73
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
Zhu, H., Luo, P., Fu, Y., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2410 · Cited by 68
Kao, S., Lee, W.-J., Chang, J., Chow, J., Chung, C., Hung, W.-Y., & Chien, M. (2016) · Environmental Toxicology · doi:10.1002/tox.22336 · Cited by 67 · cited 1×
“Moreover, DMY increased intracellular peroxide and sustained the activation of ERK1/2 and JNK1/2 signaling pathways, which was reversed by ROS scavenger N-acetylcysteine (NAC) (Kao et al., 2017).”
BackgroundRen, Z., Yan, P., Zhu, L.-S., Yang, H., Zhao, Y., Kirby, B. P., Waddington, J. L., & Zhen, X. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4761-z · Cited by 66
Zhao, Z., Yin, J.-Q., Wu, M.-S., Song, G., Xie, X.-B., Zou, C., Tang, Q., Wu, Y., Lu, J., Wang, Y., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0067 · Cited by 65 · cited 1×
“Mechanistic analysis showed that the anti-tumor potential of DMY may be attributed to GSK3β inactivation via AMPKα and p38 activation (Zhao et al., 2014).”
BackgroundJia, L.-G., Sheng, Z.-W., Xu, W., Li, Y.-X., Liu, Y.-G., Xia, Y., & Zhang, J. (2011) · Molecular Plant · doi:10.1093/mp/ssr089 · Cited by 64
Self-citationRavindran, S., Hussain, S. J., Boovarahan, S. R., & Kurian, G. A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.002 · Cited by 62 · cited 1×
“The attenuation effects on CUMS-induced depression-related and anxiety-related behaviors were attributed to the elevated BDNF pathway (Ren et al., 2018).”
BackgroundXia, J., Guo, S., Fang, T., Feng, D., Zhang, X., Zhang, Q., Liu, J., Liu, B., Li, M., & Zhu, R. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.01.014 · Cited by 60 · cited 2×
“Further study indicated that DMY suppressed mTOR activation via regulating ERK1/2, AMPK, and PI3K/Akt (Xia et al., 2014).”
BackgroundXu, Y., Wang, S., Chan, H. F., Lu, H., Lin, Z., He, C., & Chen, M. (2017) · Scientific Reports · doi:10.1038/srep46060 · Cited by 60
Zeng, Y., Peng, Y., Tang, K., Wang, Y. Q., Zhao, Z. Y., Wei, X. Y., & Xu, X. L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.124 · Cited by 60
Brain-derived neurotrophic factor increase during treatment in severe mental illness inpatients
Nuernberg, G. L., Aguiar, B., Bristot, G., Fleck, M. P., & Rocha, N. S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.227 · Cited by 56 · cited 1×
“However, ADR has strong cardiotoxicity to induce myocardial cells apoptosis (Praga et al., 1979).”
BackgroundHuang, H., Liao, C., Peng, C.-C., Lim, J.-M., Siao, J.-H., Wei, C.-M., Chen, C.-C., Wu, C.-S., & Chang, T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.08.023 · Cited by 56
Chen, Y., Lv, L., Pi, H., Qin, W., Chen, J., Guo, D., Lin, J., Chi, X., Jiang, Z., Yang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12894 · Cited by 55
Self-citationHuang, H., HU, M., Zhao, R., Li, P., & Li, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2705 · Cited by 53 · cited 1×
“Moreover, Chk2 siRNA, but not p53 or Chk1, abolished G2/M arrest by DMY (Huang et al., 2013).”
BackgroundLiu, P., Zou, D., Chen, K., Zhou, Q., Gao, Y., Huang, Y., Zhu, J., Zhang, Q., & Mi, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9627-y · Cited by 53
Self-citationLiu, L., Zhou, M., Lang, H., Zhou, Y. G., & Mi, M. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13403 · Cited by 53 · cited 2×
“The researchers found that DMY promoted glucose uptake in both adipogenic differentiation of 3T3-L1 cells and dexamethasone-treated differentiated adipocytes (Liu et al., 2018).”
BackgroundDihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression
Tang, N., Ma, J., Wang, K. S., Mi, C., Lv, Y., Piao, L. X., Xu, G. H., Li, X., Lee, J. J., & Jin, X. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2799-6 · Cited by 50 · cited 1×
“Many experiments found that polyphenolics had low oral bioavailability (Teng and Chen, 2018).”
BackgroundBlood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease
Jin, Y., Singh, P., Chung, H., & Hong, S. (2018) · Nutrients · doi:10.3390/nu10050564 · Cited by 45
Zhou, D.-Z., Sun, H.-Y., Yue, J.-Q., Peng, Y. G., Chen, Y., & Zhong, Z. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1328552 · Cited by 45 · cited 1×
“Additionally, DMY induced apoptosis and cytoprotective autophagy through ROS-NF-κB signaling in human melanoma cells (Zhou et al., 2017).”
BackgroundSelf-citationZhang, Z., Zhang, H., Chen, S., Yan, X., Yao, A.-J., Liao, Q., Han, L., Zou, Z., & Zhang, X. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.01.003 · Cited by 41 · cited 1×
“These data suggested that DMY induced mitochondriamediated apoptosis in HepG2 cells via Akt/Bad pathway downregulation (Zhang et al., 2017).”
BackgroundMeng, G., Yang, S., Chen, Y., Yao, W., Zhu, H., & Zhang, W. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.948635 · Cited by 38 · cited 1×
“In summary, DMY prevented endotoxemia-induced AKI by reducing calcium aggregation and inhibiting ROS generation (Wang et al., 2016).”
BackgroundSelf-citationLiang, J., Shen, Y., Shao, X. M., Scott, M., Ly, E., Wong, S. C., Nguyen, A. T., Tan, K., Kwon, O. J., Olsen, R. W., et al. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1291-5 · Cited by 37 · cited 2×
“Moreover, DMY prevented FAE-induced changes in responsiveness of synaptic and extrasynaptic GABAARs to a selective GABAAR agonist (Liang et al., 2014).”
BackgroundDihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells
Zeng, G., Liu, J., Chen, H., Liu, B., Zhang, Q., Li, M., & Zhu, R. (2014) · Oncology Reports · doi:10.3892/or.2014.3160 · Cited by 36 · cited 1×
“Previous studies demonstrated that DMY suppressed cell proliferation, induced cell cycle arrest at G1/S phase and promoted apoptosis of melanoma SK-MEL-28 cells, which might be related to the enhanced expression of Bax proteins and decreased levels of IKK-α, NF-κB, and P-p38 (Zeng et al., 2014).”
BackgroundAnti-inflammatory effects of dihydromyricetin in a mouse model of asthma
Xu, B., Huang, S., Wang, C., Zhang, H., Fang, S., & Zhang, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6428 · Cited by 36
ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
Chan, S. Y., Matthews, E., & Burnet, P. W. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00169 · Cited by 35
Liu, B., Zhou, W., CHEN, X., Xu, F., Chen, Y., Liu, J., Zhang, Q., Bao, S., Chen, N., Li, M., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2891 · Cited by 34 · cited 1×
“DMY also inhibited cell viability and promoted apoptosis in mouse hepatocellular carcinoma Hepal-6 cells, which was associated with ROS production down-regulation via decreasing transforming growth factor β (TGF-β), Smad3 and nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) expression (Liu et al., 2015).”
BackgroundSelf-citationWang, P., Luo, L., Shen, Q., Shi, G., Mohammed, A., Ni, S., & Wu, X. Y. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.013 · Cited by 34 · cited 1×
“The detailed electrophysiological mechanism of DMY is to inhibit sodium currents (INa) and to enhance calcium current (IK1) (Wang et al., 2014).”
BackgroundApoptosis inhibition effect of Dihydromyricetin against UVA-exposed human keratinocyte cell line
He, Z., Zhang, L., Zhuo, C., Jin, F., & Wang, Y. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.05.002 · Cited by 32
Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells
JI, F., Tian, X., Liu, X. W., Fu, L., Wu, Y., Fang, X., & Jin, H. Y. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.1.7 · Cited by 31
Tang, K., Wang, F., Zeng, Y., Chen, X., & Xu, X. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.026 · Cited by 27
Zhao, L., Cai, C., Wang, J., Zhao, L., Li, W., Liu, C., Guan, H., Zhu, Y., & Xiao, J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00928 · Cited by 24
Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats
Mu, S., Li, Y., Liu, B., Wang, W., Chen, S. X., Wu, J., OuYang, L., Zhu, Y., Li, K., Zhan, M., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0801-0 · Cited by 24 · cited 1×
“In addition, DMY up-regulated Bcl-2, but down-regulated cleaved caspase3 and Bax to inhibit apoptosis (Mu et al., 2016).”
BackgroundHe, M., Zhang, Q., Shu, G., Lin, J.-C., Zhao, L., Liang, X.-X., Yin, L., Shi, F., Fu, H., & Yuan, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.030 · Cited by 16 · cited 1×
“And the enhanced differentiation was dependent on p38-STAT1 activation signaling pathway (He et al., 2018).”
Backgroundde Queiroz, A. C., Alves, H. D. S., Silva, L. H. A. C., Dias, T. D. L. M. F., Santos, M. D. S., Melo, G. M. D. A., Campesatto, E. A., Chaves, M. C. D. O., & Alexandre‐Moreira, M. S. (2014) · Natural Product Research · doi:10.1080/14786419.2013.867444 · Cited by 14 · cited 1×
“To our knowledge, flavonoids have many peculiar effects such as scavenging oxygen free radicals, anti-oxidation, anti-thrombosis, anti-inflammation, anti-tumor and so on (Jia et al., 2012; de Queiroz et al., 2014; Yang et al., 2015).”
Luo, L., Xi, C., Xu, T., Zhang, G., Qun, E., & Zhang, W. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.047 · Cited by 10 · cited 3×
“Carbon tetrachloride (CCl4) was usually applied to induce chemical liver injury characterized by hepatocyte necrosis and liver dysfunction, and high-dosage of CCl4 even led to ALF (Luo et al., 2017).”
Background
Cited by
Chang, Y., Yuan, L., Liu, J., Muhammad, I., Cao, C., Shi, C., Zhang, Y., Li, R., Li, C., & Liu, F. (2020) · Veterinary Research · doi:10.1186/s13567-020-00796-8 · Cited by 74
Metadata
- Authors
- Zhang, J., Chen, Y., Luo, H., Sun, L., Xu, M., Yu, J., Zhou, Q., Meng, G., & Yang, S.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-25
- Volume
- 9
- Pages
- 1204-1204
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2898097157
- Cited by
- 207
- References
- 56
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.